Alcohol Use Disorder Pharmacotherapy in Patients With Alcohol-Related Liver Disease: A Scoping Review
Conclusion: There are limited studies that explore AUD pharmacotherapy and ALD outcomes. Medications AUD may improve hepatic outcomes; however, further prospective studies need to be completed to explore this association.
Saved in:
| Main Authors: | Manisha Jogendran, Louis Huynh, Jennifer A. Flemming |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Wiley
2025-01-01
|
| Series: | Canadian Journal of Gastroenterology and Hepatology |
| Online Access: | http://dx.doi.org/10.1155/cjgh/6455092 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Burden of alcohol use disorder, alcohol-related liver disease, and alcohol-related liver cancer: Editorial on “Global epidemiology of alcohol-related liver disease, liver cancer, and alcohol use disorder, 2000–2021
by: Youxin Wang, et al.
Published: (2025-04-01) -
Pharmacotherapy and clinical considerations for alcohol use disorder
by: Gezelle Dali, et al.
Published: (2024-05-01) -
Global epidemiology of alcohol-related liver disease, liver cancer, and alcohol use disorder, 2000–2021
by: Pojsakorn Danpanichkul, et al.
Published: (2025-04-01) -
Lipidomic analysis of alcohol use disorder patients revealed the biomarkers for alcohol-related liver disease susceptibility
by: Dongyao Wang, et al.
Published: (2025-07-01) -
Cardiovascular Diseases and Non-Alcoholic Fatty Liver Disease: Relationship and Pathogenetic Aspects of Pharmacotherapy
by: A. V. Nelidova, et al.
Published: (2022-01-01)